Literature DB >> 33431798

Genetic complexity impacts the clinical outcome of follicular lymphoma patients.

María García-Álvarez1, Sara Alonso-Álvarez2, Isabel Prieto-Conde1, Cristina Jiménez1, M Eugenia Sarasquete1, M Carmen Chillón1, Alejandro Medina1, Ana Balanzategui1, Rebeca Maldonado1, Alicia Antón1, Marta Rodríguez3, Oscar Blanco3, Luis G Díaz4, Pilar Tamayo4, Pedro Blanco5, Carmen Esteban6, Verónica González-Calle1, Noemí Puig1, Norma Gutiérrez1, Alejandro Martín1, Ramón García-Sanz7, Marcos González1, M Dolores Caballero1, Miguel Alcoceba1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33431798      PMCID： PMC7801414          DOI： 10.1038/s41408-020-00395-y

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  15 in total

1.  M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.

Authors:  Sandra Lockmer; Weicheng Ren; Marianne Brodtkorb; Bjørn Østenstad; Björn E Wahlin; Qiang Pan-Hammarström; Eva Kimby
Journal:  Br J Haematol       Date:  2019-08-18       Impact factor: 6.998

2.  Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.

Authors:  Xiaoyu Qu; Hongli Li; Rita M Braziel; Verena Passerini; Lisa M Rimsza; Eric D Hsi; John P Leonard; Sonali M Smith; Robert Kridel; Oliver Press; Oliver Weigert; Michael LeBlanc; Jonathan W Friedberg; Min Fang
Journal:  Blood       Date:  2018-11-16       Impact factor: 22.113

3.  Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Authors:  Kilannin Krysiak; Felicia Gomez; Brian S White; Matthew Matlock; Christopher A Miller; Lee Trani; Catrina C Fronick; Robert S Fulton; Friederike Kreisel; Amanda F Cashen; Kenneth R Carson; Melissa M Berrien-Elliott; Nancy L Bartlett; Malachi Griffith; Obi L Griffith; Todd A Fehniger
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

Review 4.  The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.

Authors:  Oliver Weigert; David M Weinstock
Journal:  Blood       Date:  2017-08-07       Impact factor: 22.113

Review 5.  Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.

Authors:  Koorosh Korfi; Sara Ali; James A Heward; Jude Fitzgibbon
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

Review 6.  Critical influences on the pathogenesis of follicular lymphoma.

Authors:  Ralf Küppers; Freda K Stevenson
Journal:  Blood       Date:  2018-04-17       Impact factor: 22.113

7.  Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.

Authors:  Jayadev M Umakanthan; Javeed Iqbal; Connie L Batlevi; Alyssa Bouska; Lynette M Smith; Valerie Shostrom; Heather Nutsch; Basem M William; R Gregory Bociek; Matthew Lunning; Philip Bierman; Anas Younes; James O Armitage; Julie M Vose
Journal:  Br J Haematol       Date:  2018-12-05       Impact factor: 6.998

8.  Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients.

Authors:  María Isabel Prieto-Conde; Cristina Jiménez; María García-Álvarez; Fernando Ramos; Alejandro Medina; Rebeca Cuello; Ana Balanzategui; José M Alonso; Maria Eugenia Sarasquete; José Antonio Queizán; Miguel Alcoceba; Abelardo Bárez; Noemí Puig; Alberto Cantalapiedra; Norma C Gutiérrez; Ramón García-Sanz; Marcos González-Díaz; María Carmen Chillón
Journal:  Br J Haematol       Date:  2020-03-02       Impact factor: 6.998

9.  Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Authors:  Alessandro Pastore; Vindi Jurinovic; Robert Kridel; Eva Hoster; Annette M Staiger; Monika Szczepanowski; Christiane Pott; Nadja Kopp; Mark Murakami; Heike Horn; Ellen Leich; Alden A Moccia; Anja Mottok; Ashwini Sunkavalli; Paul Van Hummelen; Matthew Ducar; Daisuke Ennishi; Hennady P Shulha; Christoffer Hother; Joseph M Connors; Laurie H Sehn; Martin Dreyling; Donna Neuberg; Peter Möller; Alfred C Feller; Martin L Hansmann; Harald Stein; Andreas Rosenwald; German Ott; Wolfram Klapper; Michael Unterhalt; Wolfgang Hiddemann; Randy D Gascoyne; David M Weinstock; Oliver Weigert
Journal:  Lancet Oncol       Date:  2015-08-06       Impact factor: 41.316

10.  EZH2 alterations in follicular lymphoma: biological and clinical correlations.

Authors:  S Huet; L Xerri; B Tesson; S Mareschal; S Taix; L Mescam-Mancini; E Sohier; M Carrère; J Lazarovici; O Casasnovas; L Tonon; S Boyault; S Hayette; C Haioun; B Fabiani; A Viari; F Jardin; G Salles
Journal:  Blood Cancer J       Date:  2017-04-21       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.